| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.800 | None | 0.933 | 6 | 1 | 1996 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.360 | None | 1.000 | 4 | 0 | 2000 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.979 | 4 | 0 | 1998 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.700 | None | 0.963 | 3 | 0 | 1988 | 2020 | ||||||||
|
ras homolog family member A | 0.502 | 0.808 | 0.60 |
|
disease | 0.390 | None | 1.000 | 3 | 0 | 2004 | 2020 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 2011 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.975 | 2 | 0 | 1991 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.700 | None | 0.992 | 1 | 0 | 2005 | 2020 | ||||||||
|
gastrin | 0.485 | 0.808 | 2.7E-03 |
|
disease | 0.400 | None | 0.972 | 1 | 0 | 1988 | 2020 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.400 | None | 1.000 | 0 | 5 | 1998 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.400 | None | 0.980 | 0 | 3 | 1996 | 2020 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.400 | None | 0.938 | 4 | 0 | 1992 | 2019 | ||||||||
|
amphiregulin | 0.487 | 0.769 | 0.35 |
|
disease | 0.360 | None | 1.000 | 3 | 0 | 2005 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.989 | 3 | 0 | 1986 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.400 | None | 0.951 | 2 | 0 | 2001 | 2019 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.957 | 2 | 0 | 1996 | 2019 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.850 | 2 | 0 | 2001 | 2019 | ||||||||
|
prostate stem cell antigen | 0.555 | 0.615 | 0.17 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2008 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.950 | 2 | 0 | 1992 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 1987 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.912 | 2 | 0 | 1992 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.700 | None | 0.983 | 2 | 2 | 1992 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1995 | 2019 | ||||||||
|
extracellular matrix protein 1 | 0.576 | 0.731 | 4.7E-14 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
matrix metallopeptidase 7 | 0.446 | 0.885 | 1.0E-09 |
|
disease | 0.400 | None | 0.950 | 1 | 0 | 1995 | 2019 |